Previous comprehensive transcriptome analysis of Ewing sarcoma revealed several cell surface antigen candidates targeted by antibody-drug conjugates, but their accumulation in tumors and healthy organs has not been tested in vivo [4]. This evidence concerns the gene CD53 and Ewing sarcoma.